OCM Issues Precautionary Recall for Keystone Lab Cannabis Products
The New York Office of Cannabis Management issued a precautionary cannabis recall for select products tested by Keystone Lab. This recall highlights concerns about cannabis product safety and testing accuracy. Patients should verify their products…
Bridging the Gap: Medical Cannabis, Regulators, and Clinical Accountability
Medical cannabis prescribing accountability is essential for patient safety and regulatory compliance. Physicians must meet clinical standards identical to other controlled substances. This ensures evidence-based decision-making and ongoing patient…
Ohio Issues Recall on Some THC Gummies
Ohio regulators have issued a recall on certain THC gummies due to safety concerns in the state's regulated cannabis market. This Ohio THC gummy recall underscores the importance of robust product testing and consumer protection. The recall demonstrates…
Four More States Advance Bills to Allow Medical Marijuana Access in Hospitals
Four states are advancing legislation to allow medical marijuana use in hospitals, reflecting a growing trend in clinical care. This medical marijuana use in hospitals addresses patient needs in hospice, palliative care, and recovery. Current federal…
Legal Analysis: Hemp Retailers Face ‘Existential Threat,’ Possible Closure or Forced Pivots
Hemp retail store closures are imminent due to new legal bans affecting intoxicating hemp products. This legal analysis highlights the severe disruption and forced pivots facing standalone CBD and hemp retailers. Mail-order hemp sales will also be…